- Home
- LIVN vs AZTA Comparison
LIVN vs AZTA Comparison
Compare LIVN & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- AZTA
- Stock Information
- Founded
- LIVN 1987
- AZTA 1978
- Country
- LIVN United Kingdom
- AZTA United States
- Employees
- LIVN N/A
- AZTA N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AZTA Industrial Machinery/Components
- Sector
- LIVN Health Care
- AZTA Technology
- Exchange
- LIVN Nasdaq
- AZTA Nasdaq
- Market Cap
- LIVN 2.6B
- AZTA 2.4B
- IPO Year
- LIVN 1993
- AZTA 1995
- Fundamental
- Price
- LIVN $47.44
- AZTA $44.75
- Analyst Decision
- LIVN Buy
- AZTA Buy
- Analyst Count
- LIVN 7
- AZTA 4
- Target Price
- LIVN $67.14
- AZTA $58.75
- AVG Volume (30 Days)
- LIVN 447.1K
- AZTA 546.3K
- Earning Date
- LIVN 02-25-2025
- AZTA 02-05-2025
- Dividend Yield
- LIVN N/A
- AZTA N/A
- EPS Growth
- LIVN 759.09
- AZTA N/A
- EPS
- LIVN 0.43
- AZTA N/A
- Revenue
- LIVN $1,241,739,000.00
- AZTA $662,108,000.00
- Revenue This Year
- LIVN $10.18
- AZTA N/A
- Revenue Next Year
- LIVN $5.43
- AZTA $6.29
- P/E Ratio
- LIVN $110.76
- AZTA N/A
- Revenue Growth
- LIVN 11.04
- AZTA 5.36
- 52 Week Low
- LIVN $43.15
- AZTA $38.82
- 52 Week High
- LIVN $64.48
- AZTA $67.77
- Technical
- Relative Strength Index (RSI)
- LIVN 44.11
- AZTA 31.74
- Support Level
- LIVN $46.75
- AZTA $43.93
- Resistance Level
- LIVN $49.96
- AZTA $46.10
- Average True Range (ATR)
- LIVN 1.24
- AZTA 2.60
- MACD
- LIVN -0.09
- AZTA -0.77
- Stochastic Oscillator
- LIVN 21.50
- AZTA 7.00
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.